Nattel, S., Sager, P. T., Hüser, J., Heijman, J., & Dobrev, D. (2021). Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. Cardiovasc Res.
استشهاد بنمط شيكاغوNattel, Stanley, Philip T. Sager, Jörg Hüser, Jordi Heijman, و Dobromir Dobrev. "Why Translation From Basic Discoveries to Clinical Applications Is so Difficult for Atrial Fibrillation and Possible Approaches to Improving It." Cardiovasc Res 2021.
MLA استشهادNattel, Stanley, et al. "Why Translation From Basic Discoveries to Clinical Applications Is so Difficult for Atrial Fibrillation and Possible Approaches to Improving It." Cardiovasc Res 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.